Mitigating the Morbidity of Financial Toxicity in Cancer Care
- PMID: 34084573
- PMCID: PMC8087229
- DOI: 10.6004/jadpro.2021.12.3.10
Mitigating the Morbidity of Financial Toxicity in Cancer Care
Abstract
At JADPRO Live Virtual 2020, Veena Shankaran, MD, MS, reviewed data around the prevalence and risk factors for financial toxicity, discussed potential downstream consequences of financial toxicity in cancer care, and outlined four key strategies to mitigate it.
© 2021 Harborside™.
Conflict of interest statement
Dr. Shankaran had no conflicts of interest to disclose.
References
-
- Choosing Wisely. (2019)American Society of Clinical Oncology: Ten things physicians and patients should question. https://www.choosingwisely.org/societies/american-society-of-clinical-on...
-
- Yabroff, K. R, Dowling, E. C, Guy, G. P, Banegas, M. P, Davidoff, A, Han, X, … Ekwueme, D. U. (2016)Financial hardship associated with cancer in the united states: Findings from a population-based sample of adult cancer survivors. Journal of Clinical Oncology 34(3), 259–267. 10.1200/jco.2015.62.0468 - DOI - PMC - PubMed
-
- Yezefski, T, Steelquist, J, Watabayashi, K, Sherman, D, & Shankaran, V. (2018)Impact of trained oncology financial navigators on patient out-of-pocket spending. American Journal of Managed Care, 24(5 Suppl), S74–S79. https://pubmed.ncbi.nlm.nih.gov/29620814/ - PubMed
LinkOut - more resources
Full Text Sources